Clinical Trials Directory

Trials / Conditions / Urinary Tract Infection Complicated

Urinary Tract Infection Complicated

7 registered clinical trials studyying Urinary Tract Infection Complicated.

StatusTrialSponsorPhase
CompletedClinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.
NCT06996301
Doc Lab IncN/A
CompletedResistance Characteristics and Development of Diagnostic Model for Postoperative UTI in Patients With Kidney S
NCT06946667
Xingxin Jiang—
CompletedSafety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections
NCT02753946
Nabriva Therapeutics AGPhase 2 / Phase 3
CompletedEfficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
NCT02166476
Melinta Therapeutics, Inc.Phase 3
CompletedEfficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections i
NCT02168946
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)Phase 3
CompletedStudy of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
NCT02420366
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)—
CompletedCSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs)
NCT03477422
Venus Remedies LimitedPhase 3